Dr. Reddy’s launches Palonosetron Hydrochloride Injection in US Market

26 Mar 2018 Evaluate

Dr. Reddy’s Laboratories has launched Palonosetron Hydrochloride Injection, 0.25 mg (base)/ 5 mL, a therapeutic equivalent generic version of ALOXI (palonosetron hydrochloride) Injection approved by the US Food and Drug Administration (USFDA).

The ALOXI brand and generic had US sales of around $446 million MAT for the most recent twelve months ending in January 2018 according to IMS Health.

Dr. Reddy’s Palonosetron Hydrochloride Injection is available in strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one vial.

ALOXI is a registered trademark of Helsinn Healthcare SA.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1166.45 -9.10 (-0.77%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×